Thursday, April 18, 2024 2:16:02 PM
Before Abbie came to SOHM , ABBIE was considered a failure(could be as simple as too far ahead of its time). Look how long it took Stem cells therapy to become common medical practice.
But lucky for ABBIE technology and medical practices are forever evolving.
All ABBIE has to do is get the right partner with the right name attached to that partner and the stock price will explode, without the need to ever market a product themselves.
Agiluar is fishing in the right ponds and only needs one fish to bite.
At this state credibility is more important then marketing.
Recent SHMN News
- Gene Editing Company Joins Forces to Advance Gene Therapy • AllPennyStocks.com • 04/01/2024 03:46:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM